Biopsies - Active Surveillance

  1. Does an elevated PSA mean a biopsy is indicated? Mark Scholz, MD (oncologist), explains that an elevated PSA may not mean that a biopsy is indicated. Published on Oct 16, 2017
  1. Is active surveillance an option for Gleason 7 or intermediate risk prostate cancer? Mark Scholz, MD (oncologist), explains that Gleason 7, intermediate, favorable risk prostate cancer, may meet the criteria for active surveillance. Published on Oct 16, 2017
  1. Why do you prefer a “targeted” biopsy? Patient Jon Nowlin compares “targeted” biopsies to “random” biopsies, concluding that “targeted biopsies” provide more meaningful results. Published on Oct 16, 2017
  1. In your case what did a targeted biopsy reveal? Patient Jon Nowlin believes in the value of targeted biopsies as part of active surveillance protocols. Published on Oct 16, 2017
  1. Could you describe your experience with sepsis? Patient Carlos Orrillo describes the ordeal of his infection with sepsis following his initial TRUS biopsy. Published on Apr 13, 2015
  1. Why have a targeted biopsy rather than a random biopsy? Patient Lyle La Roch emphasizes the need for targeted biopsies rather than TRUS biopsies. Published on Mar 31, 2015
  1. Why have an MRI before a biopsy? Patient/physician Ferdinand Becker describes the importance of proper imaging before a biopsy. Published on Mar 31, 2015
  1. Does a multi-parametric MRI offer improvements over a TRUS biopsy? Radiologist Robert Princenthal describes how a multi-parametric MRI leads to a targeted biopsy, fewer needles and more accurate diagnosis. Published on Mar 31, 2015
  1. How often do TRUS “blind” biopsies miss higher grade cancer? Urologist Bela Denes discusses how TRUS biopsies often miss higher grade cancer, leading to error rates in Gleason scores. Published on Mar 31, 2015
  1. Why did you want to avoid a third biopsy? Patient James Goodacre describes an adverse reaction to his last TRUS “random” biopsy and how he wanted to avoid another “random” biopsy. Published on Mar 31, 2015
  1. What major concern have you found among active surveillance patients? Active Surveillance patient Mark Lichty reports how active surveillance patients choose to minimize the number of biopsies they receive. Published on Dec 04, 2014
  1. Why get an MRI before a biopsy? Patient/physician Ferdinand Becker describes the importance of proper imaging before a biopsy.  Published on Dec 04, 2014
  1. What are the advantages of a “targeted” biopsy? Radiologist Robert Princenthal describes how a multi-parametric MRI leads to a targeted biopsy, fewer needles and more accurate diagnosis. Published on Dec 04, 2014